Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary hyperparathyroidism: is there anything new?

Ann E Kearns1

  • 1Division of Endocrinology, Metabolism, & Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Comprehensive Therapy
|November 30, 2004
PubMed
Summary

Primary hyperparathyroidism is a common cause of hypercalcemia. While surgery offers a cure, the best management for mild, asymptomatic cases is still debated, though minimally invasive options exist.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-year evaluation of bone health in liver transplant patients: developing a risk score for predicting bone fragility progression beyond the first year.

Frontiers in endocrinology·2025
Same author

Systemic Osteoporosis and Osteopenia Among Periprosthetic Fractures After Total Hip Arthroplasty.

The Journal of arthroplasty·2024
Same author

Improving Handoffs After Osteoporotic Fractures.

Journal of the American Medical Directors Association·2023
Same author

Managing Bone Health in Breast Cancer.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2022
Same author

Coronary artery calcium and bone mineral density by serial CTA: Does menopausal hormone therapy modify the association?

Clinical imaging·2022
Same author

Survival in primary hyperparathyroidism over five decades (1965-2010) a population-based retrospective study.

Bone·2021

Area of Science:

  • Endocrinology
  • Surgical Oncology

Background:

  • Primary hyperparathyroidism is the most frequent cause of hypercalcemia in outpatient settings.
  • Management strategies for asymptomatic patients with mild primary hyperparathyroidism are not well-established and remain a subject of clinical debate.

Purpose of the Study:

  • To review the current understanding of primary hyperparathyroidism.
  • To discuss the controversial aspects of managing asymptomatic mild primary hyperparathyroidism.
  • To highlight surgical options, including minimally invasive approaches.

Main Methods:

  • Literature review of primary hyperparathyroidism management.
  • Analysis of current clinical practices for asymptomatic patients.
  • Evaluation of surgical outcomes for minimally invasive procedures.

Main Results:

  • Primary hyperparathyroidism is a prevalent condition leading to hypercalcemia.
  • There is no consensus on the optimal treatment for mild, asymptomatic primary hyperparathyroidism.
  • Minimally invasive surgical techniques offer a curative and less invasive treatment option.

Conclusions:

  • Surgery remains the definitive treatment for primary hyperparathyroidism.
  • Further research is needed to establish clear guidelines for managing mild, asymptomatic cases.
  • Advancements in minimally invasive surgery provide effective therapeutic alternatives.

Related Experiment Videos